Stock Events

Stock Events

Celon Pharma SA 

€5.22
13
-€0.03-0.57% Tuesday 06:13

Statistics

Day High
5.22
Day Low
5.22
52W High
5.4
52W Low
4.69
Volume
-
Avg. Volume
-
Mkt Cap
281.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 24
€0.02
Jul 23
€0.02
Jul 22
€0.06
Aug 21
€0.02
Jun 20
€0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

20MayExpected
Q3 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-32.6%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
57.77MRevenue
-18.83MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8RP.MU. It's not an investment recommendation.
Orlen.
5
PKN.WA
Captor Therapeutics.
5
CTX.WA
Powszechny Zaklad Ubezpieczen SA
4
PZU.WA
Ryvu Therapeutics.
4
RVU.WA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a global pharmaceutical company that competes in various therapeutic areas similar to those targeted by Celon Pharma.
Novartis
NVS
Mkt Cap304.1B
Novartis AG is involved in the research, development, and marketing of pharmaceutical products, directly competing with Celon Pharma in multiple markets.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline plc operates in the pharmaceutical and healthcare sector, offering products that compete in the same categories as Celon Pharma.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines across many of the same fields as Celon Pharma.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC engages in the development of pharmaceutical products that directly compete with Celon Pharma's product line.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol-Myers Squibb Company offers a range of biopharmaceutical products, competing with Celon Pharma in several therapeutic areas.
Sanofi
SNY
Mkt Cap106.01B
Sanofi operates globally in the pharmaceutical sector, with a product range that overlaps with Celon Pharma's market interests.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. focuses on pharmaceuticals in areas like immunology and oncology, directly competing with Celon Pharma.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company develops and markets pharmaceutical products in areas that compete with Celon Pharma's focus.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.37B
Teva Pharmaceutical Industries Limited manufactures generic and specialty medicines, competing with Celon Pharma in various therapeutic areas.

About

Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm, undertaking the investigation, development, production, and distribution of diverse medicinal formulations. Its business model is structured around two principal areas: generic drug offerings and innovative therapeutic solutions. The company's product line addresses a range of health challenges, including oncological conditions, neurological disorders, diabetes, and other metabolic complaints. Established in 2002, this enterprise is situated in Lomianki, Poland, and functions as a subsidiary of Glatton Sp. z o.o.
Show more...
CEO
Maciej Wieczorek
Employees
564
Country
Poland
ISIN
PLCLNPH00015
WKN
000A2DJW6

Listings

STU
DE
8RP.STU
MU
DE
8RP.MU
LSE
GB
0RKX.LSE
F
DE
8RP.F

0 Comments

Share your thoughts

FAQ

What is Celon Pharma SA stock price today?▼
The current price of 8RP.MU is €5.22 EUR — it has decreased by -0.57% in the past 24 hours. Watch Celon Pharma SA stock price performance more closely on the chart.
What is Celon Pharma SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Celon Pharma SA stocks are traded under the ticker 8RP.MU.
Is Celon Pharma SA stock price growing?▼
8RP.MU stock has fallen by -0.95% compared to the previous week, the month change is a +11.3% rise, over the last year Celon Pharma SA has showed a -3.33% decrease.
What is Celon Pharma SA market cap?▼
Today Celon Pharma SA has the market capitalization of 281.13M
What is Celon Pharma SA revenue for the last year?▼
Celon Pharma SA revenue for the last year amounts to 57.77M EUR.
What is Celon Pharma SA net income for the last year?▼
8RP.MU net income for the last year is -18.83M EUR.
Does Celon Pharma SA pay dividends?▼
Yes, 8RP.MU dividends are paid annual. The last dividend per share was 0.02 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Celon Pharma SA have?▼
As of September 13, 2026, the company has 564 employees.
In which sector is Celon Pharma SA located?▼
Celon Pharma SA operates in the Health & Wellness sector.
When did Celon Pharma SA complete a stock split?▼
Celon Pharma SA has not had any recent stock splits.
Where is Celon Pharma SA headquartered?▼
Celon Pharma SA is headquartered in Lomianki, Poland.